Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-28 Sale | 2024-05-30 6:21 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Chief Scientific Officer | 300,000 | $34.3 | $10,290,000 | 0 (Indirect Direct) | View |
| 2023-03-01 Sale | 2023-03-02 4:17 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 40,000 | $24.21 | $968,231 | 2,355,553 (Indirect) | View |
| 2023-02-01 Sale | 2023-02-02 7:26 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 40,000 | $24.93 | $997,210 | 2,395,553 (Indirect) | View |
| 2023-01-03 Sale | 2023-01-04 5:53 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 40,000 | $23.71 | $948,598 | 2,475,553 (Indirect Direct) | View |
| 2022-12-06 Sale | 2022-12-07 4:30 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 40,000 | $27.22 | $1,088,683 | 2,475,553 (Indirect) | View |
| 2022-11-01 Sale | 2022-11-02 5:04 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 40,000 | $33.51 | $1,340,387 | 2,515,553 (Indirect) | View |
| 2022-10-04 Sale | 2022-10-05 4:15 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 40,000 | $27.82 | $1,112,813 | 2,555,553 (Indirect) | View |
| 2022-09-06 Sale | 2022-09-07 4:57 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 40,000 | $14.91 | $596,274 | 2,595,553 (Indirect) | View |
| 2022-08-02 Sale | 2022-08-04 4:33 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 40,000 | $18 | $719,835 | 2,635,553 (Indirect) | View |
| 2022-07-07 Sale | 2022-07-08 4:03 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 40,000 | $17.17 | $686,800 | 2,675,553 (Indirect) | View |
| 2022-04-05 Sale | 2022-04-07 4:11 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 400 | $25.04 | $10,016 | 2,715,553 (Indirect) | View |
| 2021-03-24 Sale | 2021-03-24 7:12 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 17,000 | $19.02 | $323,340 | 2,715,953 (Indirect) | View |
| 2021-02-16 Sale | 2021-02-18 5:08 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 17,000 | $25.9 | $440,300 | 2,732,953 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-30 Disposition | 2024-05-30 6:21 pm | N/A N/A | Inhibrx Inc. | INBX | Eckelman Brendan P. Chief Scientific Officer | 1,895,553 | $30 | 0 (Indirect) | View |
| 2024-05-30 Disposition | 2024-05-30 6:21 pm | N/A 2031-01-15 | Inhibrx Inc. | INBX | Eckelman Brendan P. Chief Scientific Officer | 33,334 | $0 | 0 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-30 6:09 pm | N/A 2034-05-30 | Inhibrx Biosciences Inc. | INXB | Eckelman Brendan P. Chief Scientific Officer | 648,888 | $0 | 215,000 (Direct) | View |
| 2024-05-22 Exercise | 2024-05-24 6:15 pm | N/A 2031-01-15 | Inhibrx Inc. | INBX | Eckelman Brendan P. Chief Scientific Officer | 5,010 | $34.12 | 33,334 (Direct) | View |
| 2024-03-13 Exercise | 2024-03-15 4:48 pm | N/A 2031-01-15 | Inhibrx Inc. | INBX | Eckelman Brendan P. Chief Scientific Officer | 1,898 | $35.33 | 9,177 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-12 6:04 pm | N/A 2021-01-15 | Inhibrx Inc. | INBX | Eckelman Brendan P. Chief Scientific Officer | 19,898 | $35.25 | 142,384 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-12 6:04 pm | N/A 2021-01-15 | Inhibrx Inc. | INBX | Eckelman Brendan P. Chief Scientific Officer | 2,150 | $35.75 | 142,384 (Direct) | View |
| 2024-03-12 Exercise | 2024-03-12 6:04 pm | N/A 2033-01-03 | Inhibrx Inc. | INBX | Eckelman Brendan P. Chief Scientific Officer | 4,152 | $35.25 | 142,384 (Direct) | View |
| 2024-03-11 Exercise | 2024-03-12 6:04 pm | N/A 2021-01-15 | Inhibrx Inc. | INBX | Eckelman Brendan P. Chief Scientific Officer | 6,877 | $35.3 | 142,384 (Direct) | View |
| 2024-03-11 Exercise | 2024-03-12 6:04 pm | N/A 2033-01-03 | Inhibrx Inc. | INBX | Eckelman Brendan P. Chief Scientific Officer | 6,681 | $35.33 | 142,384 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-04 5:53 pm | N/A 2033-01-03 | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 40,000 | $0 | 2,475,553 (Direct) | View |
| 2022-09-13 Gift | 2022-09-14 4:09 pm | N/A N/A | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 240,000 | $0 | 160,000 (Indirect) | View |
| 2020-12-04 Gift | 2021-01-19 4:16 pm | N/A N/A | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 240,000 | $0 | 120,000 (Indirect) | View |
| 2021-01-15 Option Award | 2021-01-19 4:16 pm | N/A 2021-01-15 | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 40,000 | $0 | 120,000 (Direct) | View |
Ownership | 2020-08-18 7:25 pm | N/A N/A | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer 10% Owner | 0 | $0 | 2,749,953 (Indirect) | View |